Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle (Q37845220)

24 August 2017

1 reference

title

Peripheral effects of the endocannabinoid system in energy homeostasis: adipose tissue, liver and skeletal muscle (English)

1 reference

24 August 2017

endocannabinoid system

0 references

author

Vincenzo Di Marzo

series ordinal

3

1 reference

24 August 2017

Cristoforo Silvestri

1

0 references

author name string

Alessia Ligresti

series ordinal

2

1 reference

24 August 2017

1 September 2011

1 reference

Reviews in Endocrine and Metabolic Disorders

24 August 2017

1 reference

24 August 2017

12

1 reference

24 August 2017

3

1 reference

24 August 2017

153-162

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-011-9167-3

24 August 2017

0 references

cites work

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

12 December 2020

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

12 December 2020

Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin

1 reference

12 December 2020

Effects of cannabinoid receptors on skeletal muscle oxidative pathways

1 reference

12 December 2020

Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age.

1 reference

12 December 2020

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

1 reference

12 December 2020

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

12 December 2020

Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats

1 reference

12 December 2020

Conversion of 4-cyanomethyl-pyrazole-3-carboxamides into CB1 antagonists with lowered propensity to pass the blood-brain-barrier

1 reference

12 December 2020

The role of the lipogenic pathway in the development of hepatic steatosis.

1 reference

12 December 2020

Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease

1 reference

12 December 2020

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

12 December 2020

Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase

1 reference

12 December 2020

Expression of the cannabinoid system in muscle: effects of a high-fat diet and CB1 receptor blockade

1 reference

12 December 2020

Adipose tissue as a regulator of energy balance

1 reference

12 December 2020

Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients.

1 reference

12 December 2020

Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes

1 reference

12 December 2020

The effects of rimonabant on brown adipose tissue in rat: implications for energy expenditure.

1 reference

12 December 2020

CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice

1 reference

12 December 2020

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

12 December 2020

Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects.

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

12 December 2020

Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.

1 reference

12 December 2020

Adipocyte differentiation and transdifferentiation: plasticity of the adipose organ

1 reference

12 December 2020

Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis

1 reference

12 December 2020

Identification of endocannabinoids and related compounds in human fat cells

1 reference

12 December 2020

Integrative physiology of human adipose tissue

1 reference

12 December 2020

Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.

1 reference

12 December 2020

Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious

1 reference

12 December 2020

Abdominal obesity and metabolic syndrome

1 reference

12 December 2020

Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients

1 reference

12 December 2020

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

12 December 2020

Cannabinoids and the gut: new developments and emerging concepts

1 reference

12 December 2020

Fatty liver and lipotoxicity

1 reference

12 December 2020

CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance

1 reference

12 December 2020

Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet

1 reference

12 December 2020

Endocannabinoid control of food intake and energy balance

1 reference

12 December 2020

Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance

1 reference

12 December 2020

Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balance.

1 reference

12 December 2020

Cannabinoid receptor 1 and 2 agonists increase lipid accumulation in hepatocytes

1 reference

12 December 2020

CB1 antagonists for obesity--what lessons have we learned from rimonabant?

1 reference

12 December 2020

Uncoupling proteins: a complex journey to function discovery.

1 reference

12 December 2020

AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

1 reference

12 December 2020

Brown adipose tissue: function and physiological significance

1 reference

12 December 2020

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

12 December 2020

Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet

1 reference

12 December 2020

Effects of anandamide on hepatic fatty acid metabolism

1 reference

12 December 2020

Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma

1 reference

12 December 2020

Endocannabinoids: synthesis and degradation

1 reference

12 December 2020

Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding

1 reference

12 December 2020

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease

1 reference

12 December 2020

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

1 reference

12 December 2020

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

1 reference

12 December 2020

Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.

1 reference

12 December 2020

The expression of receptors for endocannabinoids in human and rodent skeletal muscle

1 reference

12 December 2020

Pathogenesis of insulin resistance in skeletal muscle

1 reference

12 December 2020

Cannabinoid type 1 receptor blockade induces transdifferentiation towards a brown fat phenotype in white adipocytes

1 reference

12 December 2020

The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation

1 reference

12 December 2020

Reduced cannabinoid receptor 1 protein in subcutaneous adipose tissue of obese

1 reference

12 December 2020

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

12 December 2020

The endocannabinoid system and energy metabolism

1 reference

12 December 2020

The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms

1 reference

12 December 2020

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

12 December 2020

Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.

1 reference

12 December 2020

CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes

1 reference

12 December 2020

AMPK: a metabolic gauge regulating whole-body energy homeostasis

1 reference

12 December 2020

The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes

1 reference

12 December 2020

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

12 December 2020

Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control

1 reference

12 December 2020

Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors

1 reference

12 December 2020

Fatty acid amide hydrolase determines anandamide-induced cell death in the liver

1 reference

12 December 2020

Activation of the peripheral endocannabinoid system in human obesity

1 reference

12 December 2020

The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

1 reference

12 December 2020

Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.

1 reference

12 December 2020

The role of the endocannabinoid system in lipogenesis and fatty acid metabolism.

1 reference

12 December 2020

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

12 December 2020

Regulation of MAP kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells

1 reference

12 December 2020

The endocannabinoid system as an emerging target of pharmacotherapy

1 reference

12 December 2020

Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus

1 reference

12 December 2020

Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals.

1 reference

12 December 2020

Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle

1 reference

12 December 2020

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

1 reference

12 December 2020

Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle

1 reference

12 December 2020

Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats.

1 reference

12 December 2020

Cannabinoid type 1 receptor: another arrow in the adipocytes' bow.

1 reference

12 December 2020

Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated by peroxisome proliferator-activated receptor-delta

1 reference

12 December 2020

10.1007/S11154-011-9167-3

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21336842